|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
R03AC14
|
|
gptkbp:boilingPoint
|
Not applicable (decomposes)
|
|
gptkbp:CASNumber
|
gptkb:14611-51-9
|
|
gptkbp:containsElement
|
gptkb:chlorine
carbon
hydrogen
nitrogen
oxygen
|
|
gptkbp:drugClass
|
beta-2 adrenergic agonist
|
|
gptkbp:GHSClassification
|
Warning
|
|
gptkbp:hasInChIKey
|
SYPMXUHHUPOIAZ-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C12H18Cl2N2O
|
|
gptkbp:hasSMILES
|
CC(C)NCC(C1=CC=CC=C1Cl)O.Cl
|
|
gptkbp:hasUNII
|
42HK56048U
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
14611-51-9
|
|
gptkbp:isBannedInSport
|
true
|
|
gptkbp:legalStatus
|
prescription only (in some countries)
banned in food-producing animals (in many countries)
|
|
gptkbp:medicalUse
|
treatment of asthma
bronchodilator
|
|
gptkbp:meltingPoint
|
174-175 °C
|
|
gptkbp:molecularWeight
|
277.19 g/mol
|
|
gptkbp:name
|
gptkb:Clenbuterol
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1423
2783
DB01407
|
|
gptkbp:regulates
|
gptkb:WADA
gptkb:FDA
|
|
gptkbp:riskFactor
|
gptkb:H302_(Harmful_if_swallowed)
H319 (Causes serious eye irritation)
H315 (Causes skin irritation)
H335 (May cause respiratory irritation)
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
|
|
gptkbp:sideEffect
|
nervousness
tachycardia
muscle tremor
|
|
gptkbp:solubility
|
soluble in water
|
|
gptkbp:structureType
|
gptkb:phenylethanolamine
aromatic amine
|
|
gptkbp:synonym
|
Clenbuterol hydrochloride
Spiropent
|
|
gptkbp:usedFor
|
gptkb:veterinary_medicine
performance-enhancing drug
|
|
gptkbp:bfsParent
|
gptkb:Selegiline
gptkb:selegiline
|
|
gptkbp:bfsLayer
|
7
|